30.68
Astrana Health Inc stock is traded at $30.68, with a volume of 347.03K.
It is up +2.37% in the last 24 hours and up +33.62% over the past month.
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.
See More
Previous Close:
$29.97
Open:
$30.11
24h Volume:
347.03K
Relative Volume:
1.04
Market Cap:
$1.72B
Revenue:
$2.42B
Net Income/Loss:
$27.64M
P/E Ratio:
60.16
EPS:
0.51
Net Cash Flow:
$121.24M
1W Performance:
+4.60%
1M Performance:
+33.62%
6M Performance:
-14.01%
1Y Performance:
-35.99%
Astrana Health Inc Stock (ASTH) Company Profile
Name
Astrana Health Inc
Sector
Industry
Phone
(626) 282-0288
Address
1668 S. GARFIELD AVENUE, ALHAMBRA
Compare ASTH with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
ASTH
Astrana Health Inc
|
30.68 | 1.38B | 2.42B | 27.64M | 121.24M | 0.51 |
![]()
HCA
Hca Healthcare Inc
|
404.97 | 92.10B | 72.70B | 6.88B | 7.29B | 23.79 |
![]()
THC
Tenet Healthcare Corp
|
179.50 | 15.14B | 20.69B | 2.40B | 1.55B | 15.62 |
![]()
FMS
Fresenius Medical Care Ag Adr
|
25.60 | 14.58B | 20.92B | 666.06M | 1.85B | 1.1422 |
![]()
EHC
Encompass Health Corp
|
122.83 | 12.11B | 5.51B | 494.70M | 386.40M | 4.84 |
![]()
UHS
Universal Health Services Inc
|
185.58 | 11.30B | 16.08B | 1.20B | 1.06B | 17.82 |
Astrana Health Inc Stock (ASTH) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Apr-01-25 | Initiated | Barclays | Equal Weight |
Oct-14-24 | Initiated | TD Cowen | Buy |
Oct-11-24 | Initiated | KeyBanc Capital Markets | Sector Weight |
Jul-11-24 | Upgrade | Truist | Hold → Buy |
May-30-24 | Initiated | Robert W. Baird | Outperform |
Feb-26-24 | Initiated | Jefferies | Buy |
Feb-22-24 | Upgrade | BofA Securities | Neutral → Buy |
Jan-24-24 | Initiated | Stifel | Buy |
Dec-22-23 | Initiated | Truist | Hold |
Oct-17-23 | Initiated | BTIG Research | Buy |
Apr-12-23 | Initiated | BofA Securities | Neutral |
Dec-19-22 | Initiated | Lake Street | Buy |
Sep-21-22 | Initiated | William Blair | Outperform |
Jan-11-22 | Resumed | Colliers Securities | Buy |
Aug-12-21 | Initiated | Barclays | Equal Weight |
View All
Astrana Health Inc Stock (ASTH) Latest News
Published on: 2025-08-21 02:05:33 - newsyoung.net
Is There Enough Volume to Lift Astrana Health Inc.Fed Meeting & Low Risk High Win Rate Picks - classian.co.kr
Astrana Health Stock Up 3% After Earnings Beat and Revenue Forecast BoostNews and Statistics - IndexBox
Why Astrana Health (ASTH) Stock Is Trading Up Today - ca.finance.yahoo.com
Can Astrana Health Inc. navigate macro headwindsSwing Trade & Weekly Top Gainers Alerts - classian.co.kr
Will Astrana Health Inc. stock recover after recent drop2025 Market Overview & Precise Buy Zone Tips - Newser
Will Astrana Health Inc. see short term momentumTrade Volume Report & Short-Term High Return Ideas - Newser
How high can Astrana Health Inc. stock price go in 2025July 2025 Highlights & Consistent Growth Equity Picks - Newser
Key resistance and support levels for Astrana Health Inc.2025 Institutional Moves & Growth Focused Entry Point Reports - Newser
Combining machine learning predictions for Astrana Health Inc.Earnings Beat & Free Community Consensus Stock Picks - Newser
What makes Astrana Health Inc. stock price move sharplyJuly 2025 Sentiment & Daily Oversold Stock Bounce Ideas - thegnnews.com
Tick level data insight on Astrana Health Inc. volatility2025 Market Trends & Weekly High Return Stock Forecasts - Newser
Astrana Health Inc. stock trend outlook and recovery path2025 Technical Overview & Fast Entry High Yield Stock Tips - Newser
Sentiment analysis tools applied to Astrana Health Inc.M&A Rumor & AI Driven Stock Reports - Newser
Candlestick Signal Suggests Reversal in Astrana Health Inc.July 2025 Opening Moves & Momentum Based Trading Ideas - thegnnews.com
The 5 Most Interesting Analyst Questions From Astrana Health’s Q2 Earnings Call - TradingView
Astrana Health, agilon health, Guardant Health, AdaptHealth, and Pediatrix Medical Group Stocks Trade Up, What You Need To Know - Yahoo Finance
Astrana Health, agilon health, Guardant Health, AdaptHealth, and Pediatrix Medical Group Stocks Trade Up, What You Need To Know | FinancialContent - FinancialContent
ASTH or USPH: Which Is the Better Value Stock Right Now? - Yahoo Finance
Astrana Health Inc. Shines in Q2 2025 Earnings Call - MSN
Astrana Health (ASTH) Lifts Revenue Outlook After Acquisition—Is Profitability Taking a Back Seat? - simplywall.st
Zacks.com featured highlights include Astrana Health, BJ's Restaurants, KT Corporation and Global Ship Lease - Yahoo Finance
ASTH Q2 Deep Dive: Prospect Acquisition and Full-Risk Expansion Drive Outlook Shift - Yahoo Finance
Astrana Health And 2 Insider Favorites For High Growth - Yahoo Finance
Historical volatility pattern of Astrana Health Inc. visualizedFree Stock Selection With High Accuracy - Newser
Is Astrana Health Inc. stock undervalued right nowFree Big Mover Stock Alerts - classian.co.kr
Astrana Health, Inc. (ASTH) Q2 Earnings Lag Estimates - MSN
Truist Financial Keeps Their Buy Rating on Astrana Health (ASTH) - The Globe and Mail
Is Astrana Health’s (ASTH) Focus on Growth Over Margins Reshaping Its Long-Term Value Proposition? - simplywall.st
BofA Securities Maintains Astrana Health(ASTH.US) With Buy Rating - 富途牛牛
Astrana Health : Investor Presentation – August 2025 - MarketScreener
Astrana Health's Strategic Shift to Full-Risk Contracts: A High-Risk, High-Reward Bet in Value-Based Care? - AInvest
Transcript : Astrana Health, Inc., Q2 2025 Earnings Call, Aug 07, 2025 - MarketScreener
S&P 500 Moves Higher; Under Armour Shares Tumble After Q1 Results - Benzinga
SoundHound AI, Ouster, Globalstar, Doximity, JFrog And Other Big Stocks Moving Higher On Friday - Benzinga
Astrana Health Soars 32.6% on Surprising Revenue Surge—What’s Next for the Healthcare Giant? - AInvest
Earnings call transcript: Astrana Health Q2 2025 misses EPS, beats revenue - Investing.com
Earnings call transcript: Astrana Health Q2 2025 misses EPS, beats revenue By Investing.com - Investing.com South Africa
Astrana Health Q2 2025 slides: Revenue surges 35% amid declining margins By Investing.com - Investing.com South Africa
Astrana Health Q2 2025 slides: Revenue surges 35% amid declining margins - Investing.com Australia
Astrana Health (NASDAQ:ASTH) Posts Better-Than-Expected Sales In Q2, Stock Soars - TradingView
Astrana Health Inc. Reports Strong Q2 2025 Results - TipRanks
Astrana Health Inc reports results for the quarter ended June 30Earnings Summary - TradingView
William Blair Maintains Astrana Health(ASTH.US) With Buy Rating - 富途牛牛
Astrana Health: Strong Performance and Promising Growth Prospects Drive Buy Rating - TipRanks
Astrana Health, Inc. SEC 10-Q Report - TradingView
ASTRANA HEALTH Earnings Results: $ASTH Reports Quarterly Earnings - Quiver Quantitative
Astrana Health earnings missed by $0.16, revenue topped estimates - Investing.com South Africa
Astrana Q2 revenue rises 35% but misses analyst expectations - MarketScreener
Earnings Flash (ASTH) Astrana Health, Inc. Reports Q2 Revenue $654.8M, vs. FactSet Est of $638.3M - MarketScreener
(ASTH) Astrana Health, Inc. Expects Q3 Revenue Range $925.0M$965.0M - MarketScreener
Astrana Health Inc Stock (ASTH) Financials Data
Revenue
Net Income
Cash Flow
EPS
Astrana Health Inc Stock (ASTH) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
Kitayama Mitchell W | Director |
Nov 22 '24 |
Option Exercise |
18.41 |
3,409 |
62,760 |
21,201 |
Chiang John | Director |
Nov 19 '24 |
Option Exercise |
18.41 |
1,515 |
27,891 |
17,364 |
Sim Kenneth T. | Executive Chairman |
Nov 18 '24 |
Option Exercise |
18.65 |
28,046 |
523,058 |
609,905 |
Marsh Linda | Director |
Sep 10 '24 |
Option Exercise |
15.35 |
11,000 |
168,850 |
80,714 |
Lam Thomas S. | Director |
Sep 09 '24 |
Option Exercise |
18.65 |
28,046 |
523,058 |
409,901 |
Kitayama Mitchell W | Director |
Sep 10 '24 |
Option Exercise |
15.35 |
11,000 |
168,850 |
21,314 |
Chiang John | Director |
Sep 09 '24 |
Option Exercise |
15.35 |
11,000 |
168,850 |
19,414 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):